| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.9B | $10.8B | $19.4B | $21.8B | $20.3B | $79.6B | $95.2B | $121.6B |
| Cost of Revenue | — | $6.8B | $14.4B | $15.5B | $14.3B | $60.4B | $70.0B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $1.6B | $1.3B | $1.9B | $2.8B | $2.5B | $2.6B | — | $4.9B |
| SG&A Expense | $4.1B | $4.4B | $9.2B | $12.8B | $11.7B | $12.6B | $13.9B | $18.1B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $8.7B | $1.9B | $1.6B | $2.2B | $-3.8B | $5.7B | $0.7B | $0.8B |
| EPS (Basic) | $8.20 | $1.76 | $1.46 | $1.95 | $-3.55 | $0.58 | $0.06 | $0.07 |
| EPS (Diluted) | $8.14 | $1.75 | $1.45 | $1.93 | $-3.55 | $0.58 | $0.06 | $0.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $130.2B | $123.1B | $163.0B | $187.8B | $198.9B | $253.5B | $266.0B | $309.1B |
| Current Assets | $40.6B | $37.6B | $59.8B | $66.2B | $66.3B | $88.4B | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $111.3B | $103.6B | $134.5B | $150.2B | $157.3B | $216.4B | $236.2B | $257.3B |
| Current Liabilities | $39.0B | $34.4B | $50.9B | $56.9B | $52.0B | $56.1B | — | — |
| Stockholders' Equity | $18.7B | $19.3B | $27.4B | $36.4B | $40.3B | $35.6B | $28.3B | $31.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.5B | $4.7B | $5.2B | $5.9B | $3.3B | $3.6B | $8.8B | $4.2B |
| Investing Cash Flow | $-1.2B | $-1.7B | $4.0B | $2.3B | $21.3B | $16.6B | $8.9B | $18.2B |
| Capital Expenditures | — | — | — | $1.4B | $1.3B | $3.3B | $5.8B | $7.7B |
| Financing Cash Flow | $-8.7B | $-6.7B | $-8.6B | $-5.6B | $-45.2B | $-19.9B | $-16.1B | $-31.0B |